FOLH1 and prostate cancer: PET examinations of somatostatin receptors using [68Ga]-DOTATATE or [68Ga]-DOTATOC are widely accepted worldwide, and PSMA-based PET scans are indispensable for determining therapeutic strategies for prostate cancer in clinical settings.